Evaluating effects of Acupuncture versus Mesotherapy with Calcitonin in Patients with Lumbar Spinal Canal stenosis( randomized controlled clinical trial)
Study of the effect of acupuncture and calcitonin mesotherapy compared to the control group (exercise therapy) in patients with lumbar spinal stenosis
Design
Randomized clinical trial with control group,parallel-group,double-blind,60patients
Settings and conduct
Calcitonin injections:3sessions, 1session/week.Acupuncture:10sessions, at a frequency of 3sessions/week.
evaluated before treatment, and then again at 4 and 8 weeks after the intervention through clinical visits and standardized questionnaires.
The study site:Imam Reza Clinic.
clinical supervisor and the outcome assessor will be blinded
Participants/Inclusion and exclusion criteria
Inclusion Criteria:
Age40_75 years;Completion of the consent form;Confirmation of diagnosis of lumbar spinal canal stenosis through radiography,MRI,or electromyography;At least 6 months of lumbar spinal canal stenosis symptoms(low back pain,claudication,radicular pain in the lower limbs.)
Exclusion Criteria:
Pregnancy;breastfeeding;systemic or localized infection;Uncontrolled DM;Rheumatoid,collagen vascular diseases,cancer;severe liver,kidney,heart,or respiratory diseases;bleeding disorders;use of anticoagulant drugs;Brucellosis;spinal canal surgery;diabetic neuropathy or radiculopathy;BMI>42
allergic reaction to drug used in the study;Inability to complete the questionnaire;acupuncture or calcitonin injection in the last 3months;symptoms of cauda equina syndrome(perineal numbness, urinary or fecal incontinence);Muscle weakness with MMT less than 4/5
Evaluating effects of Acupuncture versus Mesotherapy with Calcitonin in Patients with Lumbar Spinal Canal stenosis( randomized controlled clinical trial)
Public title
Effects of Acupuncture in lumbar spinal canal stenosis ; Effects of Mesotherapy with calcitonin in lumbar spinal canal stenosis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age between 40-75 years old
confirmation of the diagnosis of lumbar spinal canal stenosis by radiography, MRI, or Electrodiagnosis study.
ATleast 6 months should have passed since the onset of symptoms of lumbar spinal canal stenosis ( such as low back pain, claudication, radicular leg pain, etc.)
Exclusion criteria:
pregnancy
breastfeeding
critical systemic or local infection
uncontrolled diabetes
Rheumatic and collagen vascular diseases
cancer
history of severe hepatic, renal, cardiac, or pulmonary disease
bleeding disorders
use of anticoagulants
Brucellosis
history of spinal canal surgery
Diabetic neuropathy
Concurrent radiculopathy
BMI over 42
history of allergic reaction to the drug used in the study
presence of cauda equina syndrome symptoms(perineal numbness, urinary and fecal incontinence)
muscle weakness with manual muscle test score less than 4 out of 5
inability to communicate and complete the questionnaire
history of acupuncture or calcitonin injection in thepast three months
Age
From 40 years old to 75 years old
Gender
Both
Phase
3
Groups that have been masked
Care provider
Outcome assessor
Data analyser
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, the random allocation method will be 6-block randomization, as follows:
Group A represents individuals receiving the intervention of mesotherapy with calcitonin and therapeutic exercise.
Group B represents individuals receiving acupuncture and therapeutic exercise.
Group C represents individuals receiving therapeutic exercise only.
Next, using a random number table and assigning numbers from 0 to 9 to each possible permutation, a randomized list of 60 participants will be generated. This list will include 10 blocks of 6 participants each (6*10 = 60 total participants), and the allocation of each method to each participant will be determined.
Each participant's group allocation will be assigned through the sealed envelope method, and the analyst will be blinded to the group assignments to prevent bias in the analysis.
Blinding (investigator's opinion)
Double blinded
Blinding description
To ensure concealment, the random sequence method is placed in sealed envelopes in the possession of another person who is unaware of the research process, and the questionnaires are completed by an individual unaware of the group assignment.
Clinical caregiver: We train the person who is responsible for the care and follow-up of patients on how to complete the questionnaire. This person has no knowledge of the type of intervention the patient received. Outcome assessor: The completed questionnaires are given to a person who is unaware of the interventions performed and is asked to determine the degree of pain reduction and increase in function and weight-bearing ability and balance in each individual, according to the questionnaire.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Shiraz University of Medical Sciences
Street address
Shiraz Medical School, Imam Hossein Square, Zand Street, Shiraz
City
Shiraz
Province
Fars
Postal code
7134845794
Approval date
2025-04-22, 1404/02/02
Ethics committee reference number
IR.SUMS.MED.REC.1404.071
Health conditions studied
1
Description of health condition studied
LUMBAR SPINAL CANAL STENOSIS
ICD-10 code
M48.06
ICD-10 code description
Spinal stenosis, lumbar region
Primary outcomes
1
Description
Pain Intensity
Timepoint
Before treatment, 4 and 8 weeks after start treatment
Method of measurement
VAS(Visual)analoge scale
2
Description
function
Timepoint
Before treatment, 4 and 8 weeks after start treatment
Method of measurement
health Shortform_(survey(SF_36 Quebec scale(QBPDS disability pain(back
3
Description
Ability to hop on one leg for 5 steps
Timepoint
Before treatment, 4 and 8 weeks after start treatment
Method of measurement
hopping standard scale (SHS )
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: A)mesotherapy with calcitonine and exercises in the form of three injection sessions (two 50-unit ampoules of calcitonin + 4 cc of 2% lidocaine per session) with an interval of one week. Using sterile disposable 10cc syringes with a 12mm*0.27mm needle and one cc injection at each point. Calcitonin and lidocaine manufacturer: Caspian Tamin
Category
Treatment - Drugs
2
Description
Intervention group: B)acupuncture and exercise For acupuncture, 25 x 25 needles are inserted bilaterally at BL-23, BL-25, BL-26, BL-37, BL-40, BL-54, BL-57, LI-4, BL-60, DU-3, DU-4 to a depth of 2.5 cm in the muscles, and DU-20 is inserted intradermally and remains in the patient's body for 30 minutes / Acupuncture needle manufacturer: Huanqiu
Category
Treatment - Other
3
Description
Control group: (c) Exercise therapy . Therapeutic exercises include isometric gluteal muscle exercises, hamstring and calf muscle stretching, and knee bending to the chest. The duration of each exercise is 15 to 30 seconds and is repeated 30 time per day.
Category
Rehabilitation
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Reza Clinic
Full name of responsible person
Nazanin Rashidirezvan
Street address
Imam Reza Clinic, Namazi Square
City
Shiraz
Province
Fars
Postal code
71348-14734
Phone
+98 71 3212 7000
Fax
+98 71 3674 4673
Email
emamreza.sums@ac.ir
Web page address
https://emamreza.sums.ac.ir/
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Dr Hamid Mohammadi
Street address
zand street, shiraz university of medical sciences
City
Shiraz
Province
Fars
Postal code
7134814336
Phone
+98 71 3212 2430
Email
vcrdep@sums.ac.ir
Web page address
https://research.sums.ac.ir/
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nazanin Rashidirezvan
Position
assistant
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
no19, ghasrodasht street, Shiraz
City
Shiraz
Province
Fars
Postal code
7133844311
Phone
009871
Email
Nazaninrashidi4872@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nazanin Rashidirezvan
Position
assistant
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
no19, ghasrodasht street, Shiraz
City
Shiraz
Province
Fars
Postal code
7133844311
Phone
009871
Email
Nazaninrashidi4872@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Nazanin Rashidirezvan
Position
assistant
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
no19, ghasrodasht street, Shiraz
City
Shiraz
Province
Fars
Postal code
7133844311
Phone
009871
Email
Nazaninrashidi4872@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available